Summary Inspyr Therapeutics Inc (Inspyr), formerly Genspera Inc is a biotechnology company that concentrates on the development of novel therapies for the treatment of cancer. The company is developing treatment in the areas including liver cancer, brain and prostate cancer. It is developing drug candidates for indications including HCC, GBM, PCa and RCC. Inspyr is developing drug candidate, which can be used for the treatment of hepatocellular carcinoma, glioblastoma and prostate cancer. The c...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.